Hydatid Cyst Disease

Optimal Management of Complex Liver Involvement

Jacob Moore, BA; Varun Gupta, MD; Mohammed Y. Ahmed, MD; Barbu Gociman, MD, PhD


South Med J. 2011;104(3):222-224. 

In This Article

Abstract and Introduction


The most frequent location of hydatid cystic lesions is in the liver (up to 80% of cases), followed by the lung (about 20% of cases), and with lower reported incidence, virtually in any other organ or tissue in the body. Therefore, the case an American medical practitioner would most likely encounter, albeit still rare, is a large, symptomatic liver cyst, similar to the one presented in this report. Current techniques and reasoning concerning optimal treatment of liver hydatid cyst disease are revisited, and recommendations based on available literature regarding ideal management of such cases are presented.


Although the challenge of managing echinococcal disease is fairly common in developing countries, a surgeon practicing in the United States (US) will rarely, if ever, encounter this disease. The incidence of hydatid disease in the US is very low, with approximately 200 cases presenting per year.[1] Most cases occur within immigrant populations. Despite the fact that the diagnosis is fairly straightforward, the rarity of the disease and the lack of prospective data in the literature make choosing the optimal treatment challenging. We present the successful management of a case of complex liver hydatid disease, and provide a current review of the therapeutic options available, based on the clinical presentation of the disease.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.